908 Devices CEO sells 2,798 shares in 10b5-1 plan
908 Devices Inc. President and CEO Kevin J. Knopp reported an open-market sale of 2,798 shares of common stock at a weighted average price of $9.09 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
908 Devices Inc. President and CEO Kevin J. Knopp reported an open-market sale of 2,798 shares of common stock at a weighted average price of $9.09 per share. The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on May 20, 2025.
Following the sale, Knopp directly holds 732,825 shares of common stock. In addition, 541,223 shares are held indirectly by The Kevin J. Knopp Irrevocable Trust of 2018, for which his brother-in-law serves as trustee and has sole voting and dispositive control; Knopp may be deemed the beneficial owner of those securities.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 2,798 | $9.09 | $25K |
| holding | Common Stock | -- | -- | -- |
Footnotes (3)
- F1. This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 20, 2025.
- F2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.05 to $9.20 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4).
- F3. The shares are owned directly by The Kevin J. Knopp Irrevocable Trust of 2018. The reporting person's brother-in-law is the trustee of The Kevin J. Knopp Irrevocable Trust of 2018 and has sole voting and dispositive control with respect to all securities held by such trust. The reporting person may be deemed to be the beneficial owner of the securities held by The Kevin J. Knopp Irrevocable Trust of 2018.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
weighted average price financial
irrevocable trust financial
beneficial owner regulatory
dispositive control regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did 908 Devices (MASS) report for Kevin J. Knopp?
Was Kevin J. Knopp’s 908 Devices (MASS) stock sale under a Rule 10b5-1 plan?
What is The Kevin J. Knopp Irrevocable Trust of 2018’s role in 908 Devices (MASS) holdings?
How many 908 Devices (MASS) insider sales and buys were in this Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.